Neuronetics Inc

STIMNASDAQ · USD
2.85USD0.00 (-1.73%)
2510

Neuronetics Inc (STIM) Covered Calls

As of September 18, 2026, STIM has 3 covered call opportunities in the coming three months. Return ranges from 74.1 to 86.2% until expiration. Annualized return ranges from 128.4 to 429.5%. The nearest expiration is November 20, 2026. Maximum potential profit is $250.

Read more

Running STIM covered calls helps you generate consistent income from Neuronetics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Neuronetics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best STIM covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if STIM stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling STIM covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Neuronetics Inc covered call is worth writing.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists.

Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Income-focused investors, long-term STIM holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling STIM covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Neuronetics Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile9.52% Subdued
  • Market cap (M$)217
  • 52 weeks high-17.15%
  • 52 weeks low256.25%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$5.75
    101.75% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-03
  • P/E
  • Future P/E
  • EPS (ttm)-0.44
  • EPS growth next 5 years26.75%

As of September 18, 2026

2026-11-20635.0072.410.050.50215.0074.14429.53-1.72+0.312,3120.45
2027-02-191545.0072.410.100.80220.0075.86179.80-3.45+0.407700.70
2027-05-212455.0072.410.401.15250.0086.21128.43-13.79+0.53170.75

As of September 18, 2026

Sell covered calls with the data behind you

Find the best STIM covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial